- Home
- DRIO vs EVAX Comparison
DRIO vs EVAX Comparison
Compare DRIO & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRIO
- EVAX
- Stock Information
- Founded
- DRIO 2011
- EVAX 2008
- Country
- DRIO United States
- EVAX Denmark
- Employees
- DRIO N/A
- EVAX N/A
- Industry
- DRIO Medical/Dental Instruments
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DRIO Health Care
- EVAX Health Care
- Exchange
- DRIO Nasdaq
- EVAX Nasdaq
- Market Cap
- DRIO 21.9M
- EVAX 17.8M
- IPO Year
- DRIO N/A
- EVAX 2021
- Fundamental
- Price
- DRIO $6.68
- EVAX $2.90
- Analyst Decision
- DRIO Strong Buy
- EVAX Strong Buy
- Analyst Count
- DRIO 2
- EVAX 2
- Target Price
- DRIO $50.00
- EVAX $10.00
- AVG Volume (30 Days)
- DRIO 33.1K
- EVAX 89.0K
- Earning Date
- DRIO 11-06-2025
- EVAX 10-30-2025
- Dividend Yield
- DRIO N/A
- EVAX N/A
- EPS Growth
- DRIO N/A
- EVAX N/A
- EPS
- DRIO N/A
- EVAX N/A
- Revenue
- DRIO $27,148,000.00
- EVAX $3,176,000.00
- Revenue This Year
- DRIO N/A
- EVAX N/A
- Revenue Next Year
- DRIO $62.31
- EVAX N/A
- P/E Ratio
- DRIO N/A
- EVAX N/A
- Revenue Growth
- DRIO 41.79
- EVAX 1042.45
- 52 Week Low
- DRIO $6.60
- EVAX $1.20
- 52 Week High
- DRIO $31.00
- EVAX $17.20
- Technical
- Relative Strength Index (RSI)
- DRIO 29.43
- EVAX 50.88
- Support Level
- DRIO $8.91
- EVAX $2.71
- Resistance Level
- DRIO $10.60
- EVAX $3.04
- Average True Range (ATR)
- DRIO 0.96
- EVAX 0.20
- MACD
- DRIO -0.23
- EVAX -0.01
- Stochastic Oscillator
- DRIO 2.18
- EVAX 55.97
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.